Brind.
  1. The US is pushing to tie drug prices to foreign rates, amid global trends of price controls and health technology assessments.

The Trump administration launched a Section 301 investigation into foreign countries setting artificially low drug prices.

1 report, 1 independent Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The Trump administration launched a Section 301 investigation into foreign countries setting artificially low drug prices.

Keep exploring

Coverage

Newest first; wire copies grouped